SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vivus, Why the Slide?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (3881)9/24/1997 9:13:00 PM
From: Ken   of 3991
 
Tuna,

Did you see the blurb on Zonagen in the Business Week (9/29) Inside Wall Street section? Muse is mentioned, along with Caverject, with the implication being that they are somewhat less desireable than oral treatments such as Viagra and Vasomex.

The really interesting information is the reference to (I'm not making this up) the International Index of Erectile Dysfunction developed by Dr. Ray Rosen, who attests to the efficacy of Vasomex.

Anyway, Zonagen expects to sign a deal soon with a drug maker to sell Vasomex worldwide. Could this article have anything to do with the drop today?

Ken
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext